Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Biliary tract cancer

  • You have access
    Pemetrexed and Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer Who Failed Gemcitabine-containing Chemotherapy: A Phase II Single-arm Prospective Study
    SUNG HEE LIM, JUNG YONG HONG, JOON OH PARK, YOUNG SUK PARK and SEUNG TAE KIM
    Anticancer Research September 2023, 43 (9) 4161-4167; DOI: https://doi.org/10.21873/anticanres.16607
  • You have access
    Epithelial–Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract Cancer
    CHUNG RYUL OH, HYUNG-DON KIM, YEON-MI RYU, SEONMIN LEE, DANBEE KIM, DA SOL LEE, JAE HO JEONG, HEUNG-MOON CHANG, BAEK-YEOL RYOO, KYU-PYO KIM, MIYEON KIM, SANG-YEOB KIM and CHANGHOON YOO
    Anticancer Research February 2023, 43 (2) 645-652; DOI: https://doi.org/10.21873/anticanres.16201
  • You have access
    Efficacy and Feasibility of Adjuvant Gemcitabine Plus Cisplatin Chemotherapy After Major Hepatectomy for Biliary Tract Cancer
    SHOZO MORI, TAKU AOKI, TAKAYUKI SHIRAKI, TAKAYUKI SHIMIZU, TAKAMUNE YAMAGUCHI, KYUNG-HWA PARK, TAKATSUGU MATSUMOTO, YUHKI SAKURAOKA, YUKIHIRO ISO and KEIICHI KUBOTA
    Anticancer Research October 2021, 41 (10) 5231-5240; DOI: https://doi.org/10.21873/anticanres.15342
  • You have access
    Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection
    MASASHI UTSUMI, KOJI KITADA, NAOYUKI TOKUNAGA, YUSUKE YOSHIDA, TORU NARUSAKA, RYOSUKE HAMANO, HIDEAKI MIYASOU, YOUSUKE TSUNEMITSU, SHINYA OTSUKA and MASARU INAGAKI
    Anticancer Research April 2021, 41 (4) 2147-2155; DOI: https://doi.org/10.21873/anticanres.14987
  • You have access
    Clinical Trial of a Cancer Vaccine Targeting VEGF and KIF20A in Advanced Biliary Tract Cancer
    MUTSUNORI MURAHASHI, TOSHIHISA TSURUTA, KAZUNARI YAMADA, YASUKI HIJIKATA, HISANOBU OGATA, JUNJI KISHIMOTO, SACHIKO YOSHIMURA, TETSURO HIKICHI, YOICHI NAKANISHI and KENZABURO TANI
    Anticancer Research March 2021, 41 (3) 1485-1496; DOI: https://doi.org/10.21873/anticanres.14907
  • You have access
    Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow
    ALESSANDRO RIZZO, ANGELA DALIA RICCI, NASTASSJA TOBER, MARIA CONCETTA NIGRO, MIRTA MOSCA, ANDREA PALLONI, FRANCESCA ABBATI, GIORGIO FREGA, STEFANIA DE LORENZO, SIMONA TAVOLARI and GIOVANNI BRANDI
    Anticancer Research June 2020, 40 (6) 3013-3030; DOI: https://doi.org/10.21873/anticanres.14282
  • You have access
    Preoperative Neutrophil-to-lymphocyte Ratio Predicts Tumor-infiltrating CD8+ T Cells in Biliary Tract Cancer
    RYOTA TANAKA, KENJIRO KIMURA, SHINPEI EGUCHI, JUN TAUCHI, MASATUNE SHIBUTANI, HIROJI SHINKAWA, GO OHIRA, SADAAKI YAMAZOE, SHOGO TANAKA, RYOSUKE AMANO, HIROAKI TANAKA, MASAKAZU YASHIRO, SHOJI KUBO and MASAICHI OHIRA
    Anticancer Research May 2020, 40 (5) 2881-2887; DOI: https://doi.org/10.21873/anticanres.14264
  • You have access
    Aberrant Methylation of Tumor Suppressive miRNAs in Bile from Patients With Pancreaticobiliary Diseases
    KOUSHIRO OHTSUBO, KUNIO MIYAKE, SACHIKO ARAI, KOJI FUKUDA, NAOHIRO YANAGIMURA, CHIAKI SUZUKI, SAKIKO OTANI, YUTA ADACHI, AZUSA TANIMOTO, AKIHIRO NISHIYAMA, KANAME YAMASHITA, SHINJI TAKEUCHI, KENJI NOTOHARA, KENICHI YOSHIMURA and SEIJI YANO
    Anticancer Research October 2019, 39 (10) 5449-5459; DOI: https://doi.org/10.21873/anticanres.13738
  • You have access
    The Modified Glasgow Prognostic Score in Patients with Gemcitabine-refractory Biliary Tract Cancer
    NAOHIRO OKANO, AKIYOSHI KASUGA, KIRIO KAWAI, YOSHIYA YAMAUCHI, TAKAAKI KOBAYASHI, DAISUKE NARUGE, FUMIO NAGASHIMA and JUNJI FURUSE
    Anticancer Research March 2018, 38 (3) 1755-1761;
  • You have access
    Axitinib for Gemcitabine-refractory Advanced Biliary Tract Cancer: Report of 5 Cases
    NAOHIRO OKANO, AKIYOSHI KASUGA, KIRIO KAWAI, TAKAAKI KOBAYASHI, DAISUKE NARUGE, FUMIO NAGASHIMA and JUNJI FURUSE
    Anticancer Research July 2017, 37 (7) 3711-3715;

Pages

  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire